Douglas Elliman vs Newmark
DOUG and NMRK side by side, both in real estate. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How DOUG and NMRK compare
Newmark is the larger company, worth 13 times as much as Douglas Elliman ($1.8B against $143M).
On earnings, Douglas Elliman is cheaper: it trades at 5.4× trailing earnings, against 14.3× for Newmark.
Newmark grew revenue faster over the last twelve months (20.8% versus −2.7% for Douglas Elliman).
Newmark keeps more of each dollar of sales as profit, with a net margin of 4.1% compared with 2.5% at Douglas Elliman.
Newmark pays a dividend yielding 2.1%; Douglas Elliman does not pay one.
Newmark scores higher on the StockData Score (17 against 11 for Douglas Elliman), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | DOUG | NMRK |
|---|---|---|
| Size and price | ||
| Market cap | $143M | $1.8B |
| Share price | $1.57 | $10.18 |
| Change, 1 year | −34.9% | −38.0% |
| Change, 5 years | – | −38.2% |
| Beta (5Y) | 1.65 | 0.42 |
| Employees | 580 | 8,800 |
| StockData Score | ||
| Total score | 11 | 17 (better) |
| Valuation score | 5 | 6 (better) |
| Growth score | 0 | 3 (better) |
| Performance score | 4 | 4 |
| Health score | 2 | 3 (better) |
| Dividend score | 0 | 1 (better) |
| Valuation | ||
| P/E | 5.4× (better) | 14.3× |
| P/S | 0.1× (better) | 0.5× |
| P/B | 0.9× (better) | 1.3× |
| EV/EBITDA | 0.9× (better) | 6.0× |
| P/FCF | – | 2.3× |
| PEG | – | 0.97 |
| FCF yield | −13.1% | 43.2% (better) |
| Fair value | $4.81 | $17.40 |
| Margin of safety | 67.4% (better) | 41.5% |
| Growth | ||
| Revenue growth (TTM) | −2.7% | 20.8% (better) |
| Revenue growth, 5Y average | 5.9% | 11.6% (better) |
| Net income growth (TTM) | – | 49.0% |
| EPS growth (TTM) | – | 65.1% |
| EPS growth, 5Y average | – | 11.8% |
| Profitability | ||
| Operating margin | 3.5% | 7.7% (better) |
| Net margin | 2.5% | 4.1% (better) |
| FCF margin | −1.9% | 22.1% (better) |
| Return on equity | 16.3% (better) | 10.9% |
| Return on invested capital | 69.7% (better) | 10.2% |
| Financial health | ||
| Debt / equity | – | 0.60 |
| Net debt / EBITDA | – | 1.32 |
| Interest coverage | 17.7× | – |
| Current ratio | 1.52 (better) | 1.09 |
| Altman Z-score | 2.58 (better) | 1.59 |
| Piotroski F-score | 4 | 7 (better) |
| Dividends and buybacks | ||
| Dividend yield | – | 2.1% |
| Years of dividend growth | – | 0 |
| Buyback yield | – | 8.3% |
| Shareholder yield | 0.00% | 10.3% (better) |
| Ownership | ||
| Held by institutions | 53.1% | 64.6% |
| Held by insiders | 13.4% | 48.8% |
| Short interest, % of float | 3.1% | 6.4% |
Go deeper
- DOUG stock overview
- DOUG income statement
- DOUG valuation and score
- NMRK stock overview
- NMRK income statement
- NMRK valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.